Abstract:In most immune responses including transplant rejection, T effector cells always outnumber and outperform Tregs, and therefore means to deplete T effector cells is critical to tolerance induction. T cell apoptosis is known to be permissive to allograft tolerance, but how apoptosis of T effector cells (when and by what degree) affects the induction of Tregs in allograft tolerance remains incompletely defined. In the present study we addressed the interplay of T effector cells and Tregs both in vitro and in vivo and how such interplay impacts transplant tolerance. We found in an in vitro system that activation of T effector cells led to rapid production and consumption of IL-2, which resulted in robust effector cell proliferation in an autocrine fashion. However, presence of Foxp3+Tregs in the same culture allowed CD4+ T effector cells to produce IL-2 but unable to consume IL-2 (lack of STAT5 phosphorylation), and Tregs became the sole cell type in the culture that could use IL-2 in a paracrine fashion (strong STAT5 phosphorylation). In this setting, survival and expansion of Tregs is dependent on survival of IL-2 producing T effector cells, and the degree of Treg proliferation is contingent on levels of IL-2 from T effector cells. Strikingly, addition of Rapamycin in the culture readily induced apoptotic cell death of T effector cells, which resulted in subsequent death of Tregs due to cessation of IL-2 production (death by starvation). Interestingly, inclusion of IL-15 failed to rescue Tregs in spite of the finding that IL-15 also triggered STAT5 activation. Thus, early and massive apoptosis of T effector cells antagonized Tregs unless exogenous IL-2 is provided. In a skin transplant model, we found that Rapamycin alone showed minimal effects in prolonging skin allograft survival, but Rapamycin and IL-2 together markedly extended skin allograft survival (>40 days). Our data demonstrated new mechanistic insights on the interdependence and antagonistic effects of Tregs and T effector cells, and uncovered new aspects where IL-2 works the best in tolerance induction. These new findings may have important clinical implications.

New Insights on T Cell Apoptosis in the Induction of Treg-Dependent Dominant Tolerance

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

New Insights on Ox40 in the Control of T Cell Immunity and Immune Tolerance in Vivo

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

Regulatory T cells and transplantation tolerance.

Regulatory T-Cell Counter-Regulation by Innate Immunity Is a Barrier to Transplantation Tolerance

Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

Guiding Postablative Lymphocyte Reconstitution as a Route Toward Transplantation Tolerance

Tregs Are Important to Maintain CD4+Tconv Hypofunction in Allograft Tolerance.

Role of Tregs in Maintaining Alloreactive Tconv Hypofunction in Transplantation Tolerance

Antigen-Dependent Suppression of Alloresponses by Foxp3-Induced Regulatory T Cells in Transplantation

Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.

Promotion of Allograft Survival by CD4+CD25+ Regulatory T Cells: Evidence for in Vivo Inhibition of Effector Cell Proliferation

Regulating Regulatory T Cells to Achieve Transplant Tolerance.

T regulatory cells as an immunotherapy for transplantation.

Advances in Transplantation Tolerance

Transplant Tolerance Depends on Regulatory T Cells Induced by TGF-β-producing Regulatory B Cells (P2168)

The Effects of Rapamycin on Regulatory T Cells: Its Potential Time-Dependent Role in Inducing Transplant Tolerance.